Matrix detachment and proteasomal inhibitors diminish Sulf-2 expression in breast cancer cell lines and mouse xenografts
Open Access
- 15 February 2013
- journal article
- research article
- Published by Springer Nature in Clinical & Experimental Metastasis
- Vol. 30 (4) , 407-415
Abstract
Sulfatase 2 (Sulf-2) has been previously shown to be upregulated in breast cancer. Sulf-2 removes sulfate moieties on heparan sulfate proteoglycans which in turn modulate heparin binding growth factor signaling. Here we report that matrix detachment resulted in decreased Sulf-2 expression in breast cancer cells and increased cleavage of poly ADP-ribose polymerase. Silencing of Sulf-2 promotes matrix detachment induced cell death in MCF10DCIS cells. In an attempt to identify Sulf-2 specific inhibitor, we found that proteasomal inhibitors such as MG132, Lactacystin and Bortezomib treatment abolished Sulf-2 expression in multiple breast cancer cell lines. Additionally, we show that Bortezomib treatment of MCF10DCIS cell xenografts in mouse mammary fat pads significantly reduced tumor size, caused massive apoptosis and more importantly reduced Sulf-2 levels in vivo. Finally, our immunohistochemistry analysis of Sulf-2 expression in cohort of patient derived breast tumors indicates that Sulf-2 is significantly upregulated in autologous metastatic lesions compared to primary tumors (p < 0.037, Pearson correlation, Chi-Square analysis). In all, our data suggest that Sulf-2 might play an important role in breast cancer progression from ductal carcinoma in situ into an invasive ductal carcinoma potentially by resisting cell death.Keywords
This publication has 27 references indexed in Scilit:
- Silencing of HSulf-2 expression in MCF10DCIS.com cells attenuate ductal carcinoma in situ progression to invasive ductal carcinoma in vivoBreast Cancer Research, 2012
- Hypoxia negatively regulates heparan sulfatase 2 expression in renal cancer cell linesMolecular Carcinogenesis, 2011
- Cancer early dissemination: cancerous epithelial-mesenchymal transdifferentiation and transforming growth factor signallingThe Journal of Biochemistry, 2011
- HSulf-1 Modulates FGF2- and Hypoxia-Mediated Migration and Invasion of Breast Cancer CellsCancer Research, 2011
- A Proteasome Inhibitor, Bortezomib, Inhibits Breast Cancer Growth and Reduces Osteolysis by Downregulating Metastatic GenesClinical Cancer Research, 2010
- Human Sulfatase 2 inhibits in vivo tumor growth of MDA-MB-231 human breast cancer xenograftsBMC Cancer, 2010
- Matrix Metalloproteinase (MMP)-13 Regulates Mammary Tumor–Induced Osteolysis by Activating MMP9 and Transforming Growth Factor-β Signaling at the Tumor-Bone InterfaceCancer Research, 2010
- ErbB2 requires integrin α5 for anoikis resistance via Src regulation of receptor activity in human mammary epithelial cellsJournal of Cell Science, 2010
- Comedo-Ductal carcinoma in situ: A paradoxical role for programmed cell deathCancer Biology & Therapy, 2008
- Functions of Cell Surface Heparan Sulfate ProteoglycansAnnual Review of Biochemistry, 1999